These strong associations suggest that RBBP6 overexpression promotes tumor invasion and metastasis and that RBBP6 could possibly be used as a biomarker for a more aggressive phenotype of colon cancer. This evidence concerns the gene RBBP6 and malignant colon neoplasm.